Role summary
Lead or support the analysis, adaptation, creation, and distribution of top-tier Health Economic and Outcome Research (HEOR) to promptly achieve the best possible reimbursement and pricing for Pfizer products and/ or to enhance their labeling. This is part of an evolving system that increasingly incorporates Health Technology Assessment (HTA) and HEOR insights, underpinned by the development and application of clinical, economic, and humanistic evidence that underscores the value of Pfizer's products.
Position purpose
The purpose of this role is to attain ideal reimbursement and pricing status and product uptake for Pfizer products through; The development of novel and innovative HTA/ HEOR strategies; The development and leveraging of clinical, economic, and humanistic evidence to demonstrate the value of Pfizer's products; Engaging with external stakeholders as Payers and Key Opinion Leaders (KOLs).
Responsibilities
- Lead or support the interpretation, generation and dissemination of HEOR information and data for internal and external customers on defined business categories to demonstrate the value of Pfizer products related to emergent HTA processes and lead/support technical discussion with payers/decision makers regarding Pfizer portfolio.
- Proactively research and become familiar with a broad range of HTA/ HEOR models and closely monitor latest HTA developments and intelligence in Japan to ensure optimal HTA submission for Pfizer's HTA designated products.
- Support the industry discussion by inputting scientific knowledge and experience to ensure a pro-innovative HTA system in Japan.
- Lead or support the customization of global and/ or development of local HTA/ HEOR materials/ models/ data, leveraging all available research (clinical studies, observational studies, literature, etc.) for HTA dossiers.
- Identify the evidence needs for product/ indication in pricing strategy throughout the product life cycle, create and evolve value propositions as needed, and ensure that data is available to support those messages.
- Work with cross-functional team members in the development and execution of market access plans, and medical or marketing activities.
- Ensure compliance with corporate goals, policies and procedures, and relevant legislation at all times.
Experience and Background
- Master's Degree or higher degree in Health Economics or Public Health or related fields
- Experience in HTA/ HEOR, including Leading health economics and outcomes research, Publication in scientific or medical journals as an author
- Good understanding HTA requirements, methods, and processes in Japan
- Good understanding of the evolving external environment
- Knowledge implementing value messages and reimbursement processes
- Fluent communication in Japanese and English in both writing and speaking
Competency Required
- Scientific attitude combined with a clear focus on the business
- Ability to collaborate in cross functional teams and leadership
- Innovative and creative strategic thinking
- Teamwork/ Networking & interpersonal skills
- Change agile and act decisively
- Drive for results
- Initiative and change adaptability
Work Location Assignment: Hybrid
Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.
Market Access
#LI-PFE
What We Do
Our purpose ensures that patients remain at the center of all we do. We live our purpose by sourcing the best science in the world; partnering with others in the healthcare system to improve access to our medicines; using digital technologies to enhance our drug discovery and development, as well as patient outcomes; and leading the conversation to advocate for pro-innovation/pro-patient policies.
Why Work With Us
We are the inventors, the problem solvers, the big thinkers — those who surmount any hurdle to deliver breakthrough medicines to the people who are counting on them the most.
Gallery
Pfizer Offices
Hybrid Workspace
Employees engage in a combination of remote and on-site work.